Portfolio News
Sofinnova Capital
Nucana plc announces pricing of initial public offering
Nucana plc announces pricing of initial public offering
Related News
Moon Surgical and KARL STORZ Announce Strategic Commercial Collaboration to Advance Scalable Surgery
MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development
Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline
Mane expands partnership with Arzeda to accelerate global commercialization of Vialeaf™ REB M
Elevara Medicines appoints biotech veteran as CEO